MET is a potential target across all papillary renal cell carcinomas: result from a large molecular study of pRCC with CGH array and matching gene expression array.
Albiges, Laurence; Guegan, Justine; Le Formal, Audrey; Verkarre, Virginie; Rioux-Leclercq, Nathalie; Sibony, Mathilde; Bernhard, Jean-Christophe; Camparo, Philippe; Merabet, Zahira; Molinie, Vincent; Allory, Yves; Orear, Cedric; Couvé, Sophie; Gad, Sophie; Patard, Jean-Jacques; Escudier, Bernard.
Clin Cancer Res
; 20(13): 3411-21, 2014 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-24658158
MET as a target in papillary renal cell carcinoma.
Preservation of truncal genomic alterations in clear cell and papillary renal cell carcinomas with sarcomatoid features: An intra- and intertumoral, multifocal fluorescence in situ hybridization analysis reveals limited genetic heterogeneity.
Papillary renal cell carcinoma with cytologic and molecular genetic features overlapping with renal oncocytoma: Analysis of 10 cases.
SnapShot: Renal Cell Carcinoma.
Clear cell papillary renal cell carcinoma, renal angiomyoadenomatous tumor, and renal cell carcinoma with leiomyomatous stroma relationship of 3 types of renal tumors: a review.
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.
International cancer seminars: a focus on kidney cancer.
Whole-genome analysis of papillary kidney cancer finds significant noncoding alterations.
Single-cell exome sequencing reveals single-nucleotide mutation characteristics of a kidney tumor.